Review decisions
Showing 190 results of 633 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1694620401479
Product Type: Drug
Control Number: 253753
DIN(s): 02229056
Manufacturer: Bracco Imaging Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-06-14
Decision / Authorization Date: 2022-01-28
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1689349413724
Product Type: Drug
Control Number: 266244
DIN(s): 02522551, 02522578, 02522586, 02522594, 02522608, 02528509, 02528517, 02528525, 02528533, 02528541
Manufacturer: Novo Nordisk Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-07-20
Decision / Authorization Date: 2023-06-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1689946984717
Product Type: Drug
Control Number: 266537
DIN(s): 02470365, 02492504, 02510049, 02524252, 02526190
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-08-03
Decision / Authorization Date: 2023-07-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1689169951770
Product Type: Drug
Control Number: 265088
DIN(s): 02525755
Manufacturer: Alnylam Netherlands B.v.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-06-09
Decision / Authorization Date: 2023-05-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1687527077098
Product Type: Drug
Control Number: 264582
DIN(s): 02423898, 02470608, 02480786
Manufacturer: Pfizer Canada ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-05-26
Decision / Authorization Date: 2023-05-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1686583434436
Product Type: Drug
Control Number: 256724
DIN(s): 02480018
Manufacturer: Eli Lilly Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-09-16
Decision / Authorization Date: 2023-06-13
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1722278310406
Product Type: Drug
Control Number: 275576
DIN(s): 02243721, 02531445
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-05-24
Decision / Authorization Date: 2024-04-23
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1686686460648
Product Type: Drug
Control Number: 264612
DIN(s): 02495155, 02520893
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-05-27
Decision / Authorization Date: 2023-05-02
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1684156979784
Product Type: Drug
Control Number: 264318
DIN(s): 02456869
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-05-16
Decision / Authorization Date: 2023-04-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1685724874375
Product Type: Drug
Control Number: 262756
DIN(s): 02489597
Manufacturer: Amgen Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-24
Decision / Authorization Date: 2023-03-21